Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Alberta

$879,750.00

Neutrophil Responses in Doxorubicin-Induced Myopathy

FY 2022-23

Summary
Doxorubicin is a very effective anti-cancer drug. Unfortunately, the administration of doxorubicin hurts several muscles including the heart by reducing their mass or by causing a weakening. Here, we propose to study how the cells that protect the body against infection participate in this process. We have seen that a type of defence cell called neutrophil infiltrates muscles after doxorubicin injection and, we believe, that they produce factors that induce the destruction of muscle mass.
Program
Project Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
469226
Name
Clemente Casares Javier
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology
Projecttitle
Neutrophil Responses in Doxorubicin-Induced Myopathy
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$879,750
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Doxorubicin; Inflammation; Myopathy; Wasting
Abstract
Doxorubicin is a very effective anti-cancer drug. Unfortunately, the administration of doxorubicin hurts several muscles including the heart by reducing their mass or by causing a weakening. Here, we propose to study how the cells that protect the body against infection participate in this process. We have seen that a type of defence cell called neutrophil infiltrates muscles after doxorubicin injection and, we believe, that they produce factors that induce the destruction of muscle mass.
Competitiondate
202209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Clemente Casares, Javier
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $879,750~ $0~
University of Alberta - $879,750 Grant (2022-23) | Canada Spends